Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Novartis Pharmaceuticals UK Ltd
Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
Telephone: +44 (0)1276 692 255
Fax: +44 (0)1276 698 449
Medical Information Direct Line: +44 (0)1276 698 370
Medical Information e-mail: medinfo.uk@novartis.com
Customer Care direct line: +44 (0)845 741 9442

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 26/09/2011
PIL TOBI 300 mg/5 ml Nebuliser Solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 26/09/2011 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
  • Change to MA holder contact details
Updated on 28/05/2010 and displayed until 26/09/2011
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 23/04/2007 and displayed until 28/05/2010
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 18/04/2007 and displayed until 23/04/2007
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
  tobramycin